Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Downgrades

Downgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Truist Securities Downgrades New Relic to Hold, Lowers Price Target to $55

By Benzinga Newsdesk
January 9, 10:22 AM
Truist Securities analyst Joel Fishbein downgrades New Relic (NYSE:NEWR) from Buy to Hold and lowers the price target from $80 to $55.

NEWR

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Wells Fargo Downgrades Fiserv to Underweight, Lowers Price Target to $101

By Benzinga Newsdesk
January 9, 9:52 AM
Wells Fargo analyst Jeff Cantwell downgrades Fiserv (NASDAQ:FISV) from Equal-Weight to Underweight and lowers the price target from $106 to $101.

FISV

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

By Benzinga Newsdesk
January 9, 9:44 AM
Janney Montgomery Scott analyst Michael Gaugler downgrades South Jersey Indus (NYSE:SJI) from Buy to Neutral.

SJI

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

B of A Securities Downgrades Magna International to Neutral, Lowers Price Target to $72

By Benzinga Newsdesk
January 9, 9:36 AM
B of A Securities analyst John Murphy downgrades Magna International (NYSE:MGA) from Buy to Neutral and lowers the price target from $102 to $72.

MGA

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Paymentus Holdings to Sell, Announces $7.5 Price Target

By Benzinga Newsdesk
January 9, 8:20 AM
Goldman Sachs analyst Will Nance downgrades Paymentus Holdings (NYSE:PAY) from Neutral to Sell and announces $7.5 price target.

PAY

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Mizuho Downgrades Consolidated Edison to Neutral, Raises Price Target to $98

By Benzinga Newsdesk
January 9, 8:08 AM
Mizuho analyst Anthony Crowdell downgrades Consolidated Edison (NYSE:ED) from Buy to Neutral and raises the price target from $91 to $98.

ED

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

B of A Securities Downgrades Sea to Neutral, Lowers Price Target to $60

By Benzinga Newsdesk
January 9, 8:06 AM
B of A Securities analyst Sachin Salgaonkar downgrades Sea (NYSE:SE) from Buy to Neutral and lowers the price target from $74 to $60.

SE

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

RBC Capital Downgrades Medtronic to Sector Perform, Lowers Price Target to $89

By Benzinga Newsdesk
January 9, 7:32 AM
RBC Capital analyst Shagun Singh downgrades Medtronic (NYSE:MDT) from Outperform to Sector Perform and lowers the price target from $102 to $89.

MDT

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

SVB Leerink Downgrades Amryt Pharma to Market Perform, Lowers Price Target to $14.5

By Benzinga Newsdesk
January 9, 7:14 AM
SVB Leerink analyst Mani Foroohar downgrades Amryt Pharma (NASDAQ:AMYT) from Outperform to Market Perform and lowers the price target from $19 to $14.5.

AMYT

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Prudential Financial to Sell, Lowers Price Target to $96

By Benzinga Newsdesk
January 9, 7:10 AM
Goldman Sachs analyst Alex Scott downgrades Prudential Financial (NYSE:PRU) from Neutral to Sell and lowers the price target from $98 to $96.

PRU

Posts pagination

Previous 1 … 118 119 120 … 277 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service